Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 1 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 2 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20125
20131
20141
20151
20182
20191
20202
20211
20232
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Recruiting2
Active, not recruiting1
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Cambridge7
Novartis Pharmaceuticals2
Novo Nordisk A/S2
Daniela Elleri1
GlaxoSmithKline1
ITB-Med LLC1
Imcyse SA1
Medical University of Graz1
SAb Biotherapeutics, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 123
Diabetes Mellitus6
Autoimmune Diseases2
Hypoglycemia2
Albuminuria1
Diabetic Nephropathies1
Endocrine System Diseases1
Glucose Metabolism Disorders1
Heart Failure1
Hypoxia1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.